Cargando…
Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure
OBJECTIVE: The antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are multisystem diseases of the small blood vessels. Patients experience irreversible damage and psychological effects from AAV and its treatment. An international collaboration was created to investigate the im...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759851/ https://www.ncbi.nlm.nih.gov/pubmed/29379322 http://dx.doi.org/10.2147/PROM.S144992 |
_version_ | 1783291281662803968 |
---|---|
author | Robson, Joanna C Dawson, Jill Cronholm, Peter F Milman, Nataliya Kellom, Katherine S Ashdown, Susan Easley, Ebony Farrar, John T Gebhart, Don Lanier, Georgia McAlear, Carol A Peck, Jacqueline Luqmani, Raashid A Shea, Judy A Tomasson, Gunnar Merkel, Peter A |
author_facet | Robson, Joanna C Dawson, Jill Cronholm, Peter F Milman, Nataliya Kellom, Katherine S Ashdown, Susan Easley, Ebony Farrar, John T Gebhart, Don Lanier, Georgia McAlear, Carol A Peck, Jacqueline Luqmani, Raashid A Shea, Judy A Tomasson, Gunnar Merkel, Peter A |
author_sort | Robson, Joanna C |
collection | PubMed |
description | OBJECTIVE: The antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are multisystem diseases of the small blood vessels. Patients experience irreversible damage and psychological effects from AAV and its treatment. An international collaboration was created to investigate the impact of AAV on health-related quality of life (HRQoL), and develop a disease-specific patient-reported outcome measure to assess outcomes of importance to patients. METHODS: Patients with AAV from the UK, USA, and Canada were interviewed to identify salient aspects of HRQoL affected by AAV. The study was overseen by a steering committee including four patient research partners. Purposive sampling of interviewees ensured representation of a range of disease manifestations and demographics. Inductive analysis was used to identify themes of importance to patients; these were further confirmed by a free-listing exercise in the US. Individual themes were recast into candidate items, which were scrutinized by patients, piloted through cognitive interviews and received a linguistic and translatability evaluation. RESULTS: Fifty interviews, conducted to saturation, with patients from the UK, USA, and Canada, identified 55 individual themes of interest within seven broad domains: general health perceptions, impact on function, psychological perceptions, social perceptions, social contact, social role, and symptoms. Individual themes were constructed into >100 candidate questionnaire items, which were then reduced and refined to 35 candidate items. CONCLUSION: This is the largest international qualitative analysis of HRQoL in AAV to date, and the results have underpinned the development of 35 candidate items for a disease-specific, patient-reported outcome questionnaire. |
format | Online Article Text |
id | pubmed-5759851 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-57598512018-01-29 Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure Robson, Joanna C Dawson, Jill Cronholm, Peter F Milman, Nataliya Kellom, Katherine S Ashdown, Susan Easley, Ebony Farrar, John T Gebhart, Don Lanier, Georgia McAlear, Carol A Peck, Jacqueline Luqmani, Raashid A Shea, Judy A Tomasson, Gunnar Merkel, Peter A Patient Relat Outcome Meas Original Research OBJECTIVE: The antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are multisystem diseases of the small blood vessels. Patients experience irreversible damage and psychological effects from AAV and its treatment. An international collaboration was created to investigate the impact of AAV on health-related quality of life (HRQoL), and develop a disease-specific patient-reported outcome measure to assess outcomes of importance to patients. METHODS: Patients with AAV from the UK, USA, and Canada were interviewed to identify salient aspects of HRQoL affected by AAV. The study was overseen by a steering committee including four patient research partners. Purposive sampling of interviewees ensured representation of a range of disease manifestations and demographics. Inductive analysis was used to identify themes of importance to patients; these were further confirmed by a free-listing exercise in the US. Individual themes were recast into candidate items, which were scrutinized by patients, piloted through cognitive interviews and received a linguistic and translatability evaluation. RESULTS: Fifty interviews, conducted to saturation, with patients from the UK, USA, and Canada, identified 55 individual themes of interest within seven broad domains: general health perceptions, impact on function, psychological perceptions, social perceptions, social contact, social role, and symptoms. Individual themes were constructed into >100 candidate questionnaire items, which were then reduced and refined to 35 candidate items. CONCLUSION: This is the largest international qualitative analysis of HRQoL in AAV to date, and the results have underpinned the development of 35 candidate items for a disease-specific, patient-reported outcome questionnaire. Dove Medical Press 2018-01-04 /pmc/articles/PMC5759851/ /pubmed/29379322 http://dx.doi.org/10.2147/PROM.S144992 Text en © 2018 Robson et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Robson, Joanna C Dawson, Jill Cronholm, Peter F Milman, Nataliya Kellom, Katherine S Ashdown, Susan Easley, Ebony Farrar, John T Gebhart, Don Lanier, Georgia McAlear, Carol A Peck, Jacqueline Luqmani, Raashid A Shea, Judy A Tomasson, Gunnar Merkel, Peter A Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure |
title | Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure |
title_full | Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure |
title_fullStr | Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure |
title_full_unstemmed | Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure |
title_short | Health-related quality of life in ANCA-associated vasculitis and item generation for a disease-specific patient-reported outcome measure |
title_sort | health-related quality of life in anca-associated vasculitis and item generation for a disease-specific patient-reported outcome measure |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759851/ https://www.ncbi.nlm.nih.gov/pubmed/29379322 http://dx.doi.org/10.2147/PROM.S144992 |
work_keys_str_mv | AT robsonjoannac healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure AT dawsonjill healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure AT cronholmpeterf healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure AT milmannataliya healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure AT kellomkatherines healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure AT ashdownsusan healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure AT easleyebony healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure AT farrarjohnt healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure AT gebhartdon healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure AT laniergeorgia healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure AT mcalearcarola healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure AT peckjacqueline healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure AT luqmaniraashida healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure AT sheajudya healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure AT tomassongunnar healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure AT merkelpetera healthrelatedqualityoflifeinancaassociatedvasculitisanditemgenerationforadiseasespecificpatientreportedoutcomemeasure |